Search inside SEC filings
Every 10-K, 10-Q, 8-K, proxy and registration statement filed since 2001, searched by what the text actually says. Free, no account, straight through to the document.
At least 10,000 filings contain "BV"
showing the first 40- STEINMETZ MICHAEL4 · 2008-06-18Read the filing on SEC.gov →
- ARCA biopharma, Inc.SC 13G/A · 2010-02-12Read the filing on SEC.gov →
- ARYx Therapeutics, Inc.SC 13G · 2008-02-12Read the filing on SEC.gov →
- MPM BIOVENTURES 2018, L.P.4 · 2021-12-07Read the filing on SEC.gov →
- TERCICA INCSC 13G/A · 2008-02-12Read the filing on SEC.gov →
- Somaxon Pharmaceuticals, Inc.SC 13G/A · 2008-02-12Read the filing on SEC.gov →
- Pharmasset Inc4 · 2008-06-24Read the filing on SEC.gov →
- YuMe IncSC 13G · 2014-02-13Read the filing on SEC.gov →
- APPFOLIO INC (APPF)3 · 2015-06-25Read the filing on SEC.gov →
- EnteroMedics IncSC 13G/A · 2009-02-12Read the filing on SEC.gov →
- Somaxon Pharmaceuticals, Inc.SC 13D/A · 2012-07-20Read the filing on SEC.gov →
- MPM BIOVENTURES 2018, L.P.4 · 2021-11-24Read the filing on SEC.gov →
- Syndax Pharmaceuticals Inc (SNDX)SC 13G · 2017-02-09Read the filing on SEC.gov →
- UNITED PAN EUROPE COMMUNICATIONS NV10-K · 2002-04-12Read the filing on SEC.gov →
- Pharmasset Inc4 · 2008-06-23Read the filing on SEC.gov →
- iTeos Therapeutics, Inc. (ITOS)SC 13D/A · 2021-09-21Read the filing on SEC.gov →
- TEVA PHARMACEUTICAL INDUSTRIES LTDF-3 · 2003-12-12Read the filing on SEC.gov →
- MPM BIOVENTURES III QP LP4 · 2009-01-27Read the filing on SEC.gov →
- ARYx Therapeutics, Inc.SC 13D/A · 2010-10-07Read the filing on SEC.gov →
- GADICKE ANSBERT4 · 2021-12-07Read the filing on SEC.gov →
- Pacira Pharmaceuticals, Inc. (PCRX)SC 13D · 2011-02-18Read the filing on SEC.gov →
- STEINMETZ MICHAEL4 · 2011-10-06Read the filing on SEC.gov →
- MPM BIOVENTURES 2018, L.P.4 · 2021-12-02Read the filing on SEC.gov →
- GADICKE ANSBERT4 · 2021-11-24Read the filing on SEC.gov →
- SIMON NICHOLAS J III4 · 2004-10-21Read the filing on SEC.gov →
- EVNIN LUKE4 · 2021-12-07Read the filing on SEC.gov →
- DOMBKOWSKI ASHLEY L4 · 2009-01-20Read the filing on SEC.gov →
- Pacira Pharmaceuticals, Inc. (PCRX)SC 13D/A · 2013-03-21Read the filing on SEC.gov →
- SOLECTRON CORP10-Q · 2007-07-11Read the filing on SEC.gov →
- PORTOLA PHARMACEUTICALS INCSC 13G/A · 2015-02-05Read the filing on SEC.gov →
- GADICKE ANSBERT4 · 2021-04-09Read the filing on SEC.gov →
- PHARMATHENE, INC (ALT)SC 13D/A · 2016-02-12Read the filing on SEC.gov →
- Zalicus Inc.SC 13D/A · 2011-10-31Read the filing on SEC.gov →
- Ascendis Pharma A/S (ASND)SC 13G/A · 2017-02-07Read the filing on SEC.gov →
- MPM BIOVENTURES III QP LPSC 13D · 2009-07-16Read the filing on SEC.gov →
- STEINMETZ MICHAEL4 · 2008-02-06Read the filing on SEC.gov →
- MPM BIOVENTURES I LP4 · 2008-06-23Read the filing on SEC.gov →
- Radius Health, Inc.4 · 2014-06-10Read the filing on SEC.gov →
- Pharmasset Inc4 · 2007-05-04Read the filing on SEC.gov →
- HENNER DENNIS4 · 2013-02-07Read the filing on SEC.gov →
Source: the SEC’s own EDGAR full-text index, which covers filings from 2001onward. Results are ordered by EDGAR’s relevance. A filing appearing here means the phrase is in the document, nothing more. EDGAR caps its match count at 10,000 and reports anything above that as a lower bound, so the figure above is a floor rather than an exact total.